Literature DB >> 27503360

Peripheral biomarkers of stroke: Focus on circulatory microRNAs.

Murali Vijayan1, P Hemachandra Reddy2.   

Abstract

Stroke is the second leading cause of death in the world. Stroke occurs when blood flow stops, and that stoppage results in reduced oxygen supply to neurons in the brain. The occurrence of stroke increases with age, but anyone at any age can suffer from stroke. Recent research has implicated multiple cellular changes in stroke patients, including oxidative stress and mitochondrial dysfunction, inflammatory responses, and changes in mRNA and proteins. Recent research has also revealed that stroke is associated with modifiable and non-modifiable risk factors. Stroke can be controlled by modifiable risk factors, including diet, cardiovascular, hypertension, smoking, diabetes, obesity, metabolic syndrome, depression and traumatic brain injury. Stroke is the major risk factor for vascular dementia (VaD) and Alzheimer's disease (AD). The purpose of this article is to review the latest developments in research efforts directed at identifying 1) latest developments in identifying biomarkers in peripheral and central nervous system tissues, 2) changes in microRNAs (miRNAs) in patients with stroke, 3) miRNA profile and function in animal brain, and 4) protein biomarkers in ischemic stroke. This article also reviews research investigating circulatory miRNAs as peripheral biomarkers of stroke.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Circulatory microRNA; Plasma; Protein biomarker; Serum; Stroke; Vascular dementia

Mesh:

Substances:

Year:  2016        PMID: 27503360      PMCID: PMC5343760          DOI: 10.1016/j.bbadis.2016.08.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  87 in total

1.  Elevated serum S100B levels indicate a higher risk of hemorrhagic transformation after thrombolytic therapy in acute stroke.

Authors:  Christian Foerch; Michael T Wunderlich; Florian Dvorak; Marek Humpich; Timo Kahles; Michael Goertler; Jose Alvarez-Sabín; Claus W Wallesch; Carlos A Molina; Helmuth Steinmetz; Matthias Sitzer; Joan Montaner
Journal:  Stroke       Date:  2007-08-02       Impact factor: 7.914

2.  MicroRNA-103-1 selectively downregulates brain NCX1 and its inhibition by anti-miRNA ameliorates stroke damage and neurological deficits.

Authors:  Antonio Vinciguerra; Luigi Formisano; Pierpaolo Cerullo; Natascia Guida; Ornella Cuomo; Alba Esposito; Gianfranco Di Renzo; Lucio Annunziato; Giuseppe Pignataro
Journal:  Mol Ther       Date:  2014-06-23       Impact factor: 11.454

3.  Evaluation of serum S100B as a surrogate marker for long-term outcome and infarct volume in acute middle cerebral artery infarction.

Authors:  Christian Foerch; Oliver C Singer; Tobias Neumann-Haefelin; Richard du Mesnil de Rochemont; Helmuth Steinmetz; Matthias Sitzer
Journal:  Arch Neurol       Date:  2005-07

4.  Using microRNAs to understand cancer biology.

Authors:  Joanne Weidhaas
Journal:  Lancet Oncol       Date:  2009-12-18       Impact factor: 41.316

5.  Preexisting dementia in stroke patients. Baseline frequency, associated factors, and outcome.

Authors:  H Hénon; F Pasquier; I Durieu; O Godefroy; C Lucas; F Lebert; D Leys
Journal:  Stroke       Date:  1997-12       Impact factor: 7.914

Review 6.  Genetics and ischaemic stroke.

Authors:  A Hassan; H S Markus
Journal:  Brain       Date:  2000-09       Impact factor: 13.501

7.  Fibrinogen concentration and risk of ischemic stroke and acute coronary events in 5113 patients with transient ischemic attack and minor ischemic stroke.

Authors:  Peter M Rothwell; Sally C Howard; Dermot A Power; Sergei A Gutnikov; Ale Algra; Jan van Gijn; Tanne G Clark; Michael F G Murphy; Charles P Warlow
Journal:  Stroke       Date:  2004-09-02       Impact factor: 7.914

8.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

9.  MicroRNA-210 as a novel blood biomarker in acute cerebral ischemia.

Authors:  Lili Zeng; Jianrong Liu; Yongting Wang; Ling Wang; Suiqing Weng; Yaohui Tang; Chaobo Zheng; Qi Cheng; Shengdi Chen; Guo-Yuan Yang
Journal:  Front Biosci (Elite Ed)       Date:  2011-06-01

10.  Circulating miR-30a, miR-126 and let-7b as biomarker for ischemic stroke in humans.

Authors:  Guangwen Long; Feng Wang; Huaping Li; Zhongwei Yin; Chaugai Sandip; Yan Lou; Yan Wang; Chen Chen; Dao Wen Wang
Journal:  BMC Neurol       Date:  2013-11-16       Impact factor: 2.474

View more
  42 in total

1.  Identification of novel circulatory microRNA signatures linked to patients with ischemic stroke.

Authors:  Murali Vijayan; Subodh Kumar; Xiangling Yin; Dila Zafer; Vishal Chanana; Pelin Cengiz; P Hemachandra Reddy
Journal:  Hum Mol Genet       Date:  2018-07-01       Impact factor: 6.150

2.  Novel MicroRNA-455-3p and its protective effects against abnormal APP processing and amyloid beta toxicity in Alzheimer's disease.

Authors:  Subodh Kumar; Arubala P Reddy; Xiangling Yin; P Hemachandra Reddy
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-06-08       Impact factor: 5.187

Review 3.  The role of synaptic microRNAs in Alzheimer's disease.

Authors:  Subodh Kumar; P Hemachandra Reddy
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-08-20       Impact factor: 5.187

4.  Differential MicroRibonucleic Acid Expression in Cardioembolic Stroke.

Authors:  Janhavi M Modak; Meaghan Roy-O'Reilly; Liang Zhu; Ilene Staff; Louise D McCullough
Journal:  J Stroke Cerebrovasc Dis       Date:  2018-10-11       Impact factor: 2.136

Review 5.  Are microRNAs true sensors of ageing and cellular senescence?

Authors:  Justin Williams; Flint Smith; Subodh Kumar; Murali Vijayan; P Hemachandra Reddy
Journal:  Ageing Res Rev       Date:  2016-11-27       Impact factor: 10.895

Review 6.  MicroRNAs and Regeneration in Animal Models of CNS Disorders.

Authors:  Tamara Roitbak
Journal:  Neurochem Res       Date:  2019-03-15       Impact factor: 3.996

Review 7.  Exosomal miRNAs in central nervous system diseases: biomarkers, pathological mediators, protective factors and therapeutic agents.

Authors:  Xiaohuan Xia; Yi Wang; Yunlong Huang; Han Zhang; Hongfang Lu; Jialin C Zheng
Journal:  Prog Neurobiol       Date:  2019-09-19       Impact factor: 11.685

Review 8.  Biomarkers in Stress Related Diseases/Disorders: Diagnostic, Prognostic, and Therapeutic Values.

Authors:  Kuldeep Dhama; Shyma K Latheef; Maryam Dadar; Hari Abdul Samad; Ashok Munjal; Rekha Khandia; Kumaragurubaran Karthik; Ruchi Tiwari; Mohd Iqbal Yatoo; Prakash Bhatt; Sandip Chakraborty; Karam Pal Singh; Hafiz M N Iqbal; Wanpen Chaicumpa; Sunil Kumar Joshi
Journal:  Front Mol Biosci       Date:  2019-10-18

Review 9.  MicroRNA Signature of Traumatic Brain Injury: From the Biomarker Discovery to the Point-of-Care.

Authors:  Valentina Di Pietro; Kamal M Yakoub; Ugo Scarpa; Cinzia Di Pietro; Antonio Belli
Journal:  Front Neurol       Date:  2018-06-14       Impact factor: 4.003

Review 10.  Identification of clinically relevant biomarkers of epileptogenesis - a strategic roadmap.

Authors:  Michele Simonato; Denes V Agoston; Amy Brooks-Kayal; Chris Dulla; Brandy Fureman; David C Henshall; Asla Pitkänen; William H Theodore; Roy E Twyman; Firas H Kobeissy; Kevin K Wang; Vicky Whittemore; Karen S Wilcox
Journal:  Nat Rev Neurol       Date:  2021-02-16       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.